HIV VL Test Annoucement - POCTRN
The Point of Care Technology Research Network develops technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.
POCTRN and COVID-19
RADx Tech II
RADx Tech High-Performance Tests
RADx Tech Accessible Tests
Atlanta Center for Microsystems Engineered Point-of-Care Technologies
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern
Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases
null HIV VL Test Annoucement
New Funding Opportunity: Have an innovative solution to detect HIV viral load?
The National Institute of Biomedical Imaging and Bioengineering’s (NIBIB) Point of Care Technology Research Network (POCTRN) is seeking innovative technologies that determine HIV viral load and accelerate their development towards deployment at point-of-care settings.
This program is designed to meet the significant unmet need to provide better viral load testing in point-of-care settings with technologies that are both sensitive and simple to use so that people living with HIV can be better informed of their infectiveness and response to antiretroviral therapy.
Awardees will receive:
- Up to $500k in funding to help support project acceleration
- Support provided to address business, regulatory, clinical, and technical elements
- Mentorship from highly experienced experts in all four categories
The deadline for this opportunity has passed.
Please contact email@example.com.
In the News
Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration
New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology
Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19
Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration
The National Strategy From the COVID-19 Response and Pandemic Preparedness
Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Center for Complementary and Integrative Health
Fogarty International Center
Office of Behavioral and Social Sciences Research
Office of AIDS Research
Office of Disease Prevention